BB Biotech AG
Research BB Biotech AG (BBZA) on Bullrun: market cap EUR 3.11B, dividend yield 4.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBBZA
- ExchangeXETRA
- CountrySwitzerland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 3.11B
- Dividend yield4.0%
- Financial periodQ2 2026
- RevenueCHF 461.60M
- Net incomeCHF 451.17M
- Free cash flow-CHF 150.88M
Valuation Snapshot
latest market cap is EUR 3.11B; dividend yield is 4.0%.
Peer valuation comparison
Latest dividend yield is 4.03% versus a Healthcare sector median of 2.11% (91.0% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-10 | EUR 3.11B | n/a | n/a | 2.25 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.25 EUR, yield 4.0%.
About BB Biotech AG
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BB Biotech AG's market cap?
BB Biotech AG's market capitalization is EUR 3.11B.
Does BB Biotech AG pay a dividend?
BB Biotech AG has a dividend yield of 4.0%.
What does BB Biotech AG do?
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.